BioSpace News Archive

Press Releases

Henry Schein to Participate in Investor Conferences in November

October 24, 2024
·
2 min read
Press Releases

Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers

October 24, 2024
·
19 min read
Business

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

October 24, 2024
·
3 min read
Press Releases

Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic

October 24, 2024
·
3 min read
Press Releases

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million

October 24, 2024
·
3 min read
Press Releases

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results

October 24, 2024
·
1 min read
Press Releases

Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor

October 24, 2024
·
5 min read
Press Releases

Labcorp Announces 2024 Third Quarter Results

October 24, 2024
·
23 min read
Press Releases

Syros to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024

October 24, 2024
·
1 min read
Press Releases

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease

October 24, 2024
·
10 min read